Actionable news
0
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Neurocrine Biosciences's Chief Commercial Officer was just granted 70,400 options and restricted shares

Eric Benevich, Neurocrine Biosciences's Chief Commercial Officer, just received 70,400 options and restricted shares from the company. The strike prices of the options received ranged from $0.00 to $35.99, and these expire on February 05, 2026. The restricted shares don't become available to Benevich until February 05, 2020. Benevich now has at least 41,200 options, and at least 29,200 restricted shares.

Some additional info was provided as follows:

Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock. The Restricted Stock Units will vest annually at 1/4 of...

More